Capital Meets Turnaround ’24
The Ritz-Carlton - Perth
Thursday 18th July 2024
6:00 pm - 10:30 pm
The TMA WA Committee looks forward to welcoming you to the annual, sell out, Capital Meets Turnaround Gala Dinner. This year we will be joined by Katharine Giles, Managing Director and CEO of OncorRes.
Learn about Katherine’s journey from medical doctor, to venture capital manager, to medtech start up pioneer. In an interactive format, hear Katherine’s perspective on Western Australia being more than just mining, and the unique challenges – and opportunities – of raising capital in our State in the medtech space.
Thanks to our sponsors, HWL Ebsworth Lawyers and CSC.
Guest Speaker
Dr. Katharine Giles
CEO / Managing Director
Dr. Kath Giles leads OncoRes Medical, a Perth-based medtech startup focused on transforming the standard of care in breast cancer surgery. She serves as CEO, driving the company’s mission forward. In addition to her role at OncoRes, Kath holds positions as a Non-Executive Director at Sonic Healthcare and as a Director of the National Reconstruction Fund Corporation.
Before her tenure at OncoRes, Kath spent over a decade at Brandon Capital Partners, where she was a Venture Partner and Investment Manager. Prior to this, she was an Investment Manager at Stone Ridge Ventures, specializing in early-stage technology investments. Kath’s entrepreneurial journey includes founding ventures in medical apps, diagnostics, and fitness devices.
Alongside her entrepreneurial and investment achievements, Kath still practices as a medical doctor mainly working within the surgical field and has experience as a medical officer monitoring clinical trials. Before entering the commercial world, Kath spent a few years working in clinical medicine gaining a range of experience across medical and surgical specialities and critical care.
Kath Giles graduated with Honors from her medical degree (MBBS) and holds an MBA from the University of Western Australia. She is also a Graduate of the Australian Institute of Company Directors and currently serves as a Director on the Curtin Commercialisation Advisory Board.
Thursday 18th July 2024
6:00 pm - 10:30 pm